Sage Journals: Discover world-class research

Open access

Review article

First published 2017-5

Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale,evidence and clinical utility

E. David Crawford, Neal D. Shore, Daniel P. Petrylak [...]

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2016-5

Green Suzuki Coupling Reaction for Synthesis of Abiraterone Acetate and its Analogues

Xiaoqin Bian, Lizhong Wang, Jinliang Liu [...]

Journal of Chemical Research

Open access

Research article

First published 2014

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel—an Indirect Comparison

Pui S. Tan, Benjamin Haaland, Alberto J. Montero [...]

Clinical Medicine Insights: Oncology

Open access

Research article

First published 2020

One-Year,Open-Label Extension Study on the Safety and Efficacy of Abiraterone Acetate Fine Particle Formulation in Patients With Metastatic Castration-Resistant Prostate Cancer

Jillian Chapas-Reed, Cy Stein, Nicholas Squittieri [...]

Clinical Medicine Insights: Urology

Retricted access

Research article

First published 2024

Modified monitoring of abiraterone acetate-induced hepatotoxicity in prostate cancer patients

Sweta Mishra, Hannah Spencer, Katherine Kelly

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2019

Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience

Karin Purshouse, Andrew S. Protheroe

Therapeutic Advances in Urology

Retricted access

Research article

First published 2011-8

Abiraterone Acetate: Vandetanib

Michael S. Edwards, Dominic A. Solimando, J. Aubrey Waddell

Hospital Pharmacy

Open access

Research article

First published 2023

Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer

Pier Vitale Nuzzo, Francesco Ravera, Calogero Saieva [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2018

Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomes

Alessia Cavo, Alessandra Rubagotti, Elisa Zanardi [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2024-7

Evaluation of factors predicting response to abiraterone acetate in metastatic castration-resistant prostate cancer: A prospective study

Ghanshyam Kumawat, SS Yadav, Sanjeev Jaiswal [...]

Journal of Clinical Urology

Search results